New perspectives on the definition, diagnosis, and treatment of true arterial hypertension

References

• National Institute for Health and Clinical Excellence. Hypertension: the clinical management of primary hypertension in adults. NICE Clinical Guidelines 127: Methods, evidence and recommendations. London, UK: National Clinical Guidelines Centre; 2011 cited 2019 Aug 28. Available from: http://guidance.nice.org.uk/CG/Wave2/14
   Google Scholar
• Chiang CE, Wang TD, Ueng KC, et al. 2015 guidelines of the Taiwan society of cardiology and the Taiwan hypertension society for the management of hypertension. J Chin Med Assoc. 2015;78:1–47.
   PubMed Web of Science ®Google Scholar
• Wang JG. Chinese hypertension guidelines. Pulse. 2015;3:14–20.
   PubMed Web of Science ®Google Scholar
• Piper MA, Evans CV, Burda BU, et al. Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2015;162:192–204.
   PubMed Web of Science ®Google Scholar
• Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 2018;34:506–525.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127–e248.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/EHS guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021–3104.
   PubMed Web of Science ®Google Scholar
• Umemura S, Arima H, Arima S, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42. inpress. DOI:10.1038/s41440-019-0284-9.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59:904–922.
   PubMed Web of Science ®Google Scholar
• Duffy JF, Czeisler CA. Effect of light on human circadian physiology. Sleep Med Clin. 2009;4:165–177.
   PubMedGoogle Scholar
• Smolensky MH, Sackett-Lundeen LL, Portaluppi F. Nocturnal night pollution and underesposure to daytime sunlight: complementary mechanisms of circadian disruption and related diseases. Chronobiol Int. 2015;32:1029–1048.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Castriotta RJ, et al. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 2007;8:668–680.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, et al. Circadian rhythms and cardiovascular health. Sleep Med Rev. 2012;16:151–166.
   PubMed Web of Science ®Google Scholar
• Fabbian F, Smolensky MH, Tiseo R, et al. Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 2013;30:17–30.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 2017;33:4–16.
   PubMed Web of Science ®Google Scholar
• Lakatua DJ, Haus E, Halberg F, et al. Circadian characteristics of urinary epinephrine and norepinephrine from healthy young women in Japan and U.S.A. Chronobiol Int. 1986;3:189–195.
   PubMed Web of Science ®Google Scholar
• Angeli A, Gatti G, Masera R. Chronobiology of the hypothalamic-pituitary-adrenal and renin-angiotensin-aldosterone systems. In: Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag; 1992. p. 292–314.
   Google Scholar
• Sothern RB, Vesely DL, Kanabrocki EL, et al. Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol Int. 1995;12:106–120.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, et al. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 2013;30:355–410.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, et al. Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15:173–180.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens. 2011;24:383–391.
   PubMed Web of Science ®Google Scholar
• Zhao P, Xu P, Wan C, et al. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. 2011;10:CD004184.
   PubMed Web of Science ®Google Scholar
• De Giorgi A, Menegatti AM, Fabbian F, et al. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 2013;24:698–706.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. Administration-time-differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 2013;30:280–314.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu X, Huang W, et al. Evening – versus morning – dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review. Kidney Blood Press Res. 2014;39:427–440.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Battista F, Settimi L, et al. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des. 2015;21:756–772.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, et al. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 2015;21:773–790.
   PubMed Web of Science ®Google Scholar
• Stranges PM, Drew A, Rafferty P, et al. Treatment of hypertension with chronotherapy: is it time? Ann Pharmacother. 2015;49:323–334.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, et al. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 2016;39:277–292.
   PubMed Web of Science ®Google Scholar
• Sun Y, Yu X, Liu J, et al. Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: a meta-analysis. Cardiol J. 2016;23:473–481.
   PubMed Web of Science ®Google Scholar
• Bowles NP, Thosar SS, Herzig MX, et al. Chronotherapy for hypertension. Curr Hypertens Rep. 2018;20:97.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.
   PubMed Web of Science ®Google Scholar
• Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–2415.
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156–161.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Pickering TG, Hoshide S, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens. 2008;21:443–450.
   PubMed Web of Science ®Google Scholar
• Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168:2340–2346.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58:1165–1173.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Agarwal R, Borrelli S, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090–1098.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, et al. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 2014;32:2332–2340.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Otero A, et al. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 2018;39:4159–4171.
   PubMed Web of Science ®Google Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, et al. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension. 2007;49:1235–1241.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–1229.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51:55–61.
   PubMed Web of Science ®Google Scholar
• Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036–2045.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, et al. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016;67:693–700.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – the “normotensive non-dipper” paradox. Chronobiol Int. 2013;30:87–98.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, et al. Ambulatory blood pressure monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiol Int. 2015;32:1329–1342.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Ayala DE, Hermida RC. Ambulatory blood pressure monitoring (ABPM) as THE reference standard to confirm diagnosis of hypertension in adults: recommendation of the 2015 U.S. Preventive services task force (USPSTF). Chronobiol Int. 2015;32:1320–1322.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27:1629–1651.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, et al. Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol Int. 2013;30:55–67.
   PubMed Web of Science ®Google Scholar
• Hermida RC. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the Hygia Project. Chronobiol Int. 2016;33:906–936.
   PubMed Web of Science ®Google Scholar
• Yang WY, Melgarejo JD, Thijs L, et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019;322:409–420.
   PubMed Web of Science ®Google Scholar
• Mortensen RN, Gerds TA, Jeppesen JL, et al. Office blood pressure or ambulatory blood pressure for the prediction of cardiovascular events. Eur Heart J. 2017;38:3296–3304.
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–935.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. Decrease in urinary albumin excretion associated to the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 2005;46:960–968.
   PubMed Web of Science ®Google Scholar
• Kario K, Hoshide S, Shimizu M, et al. Effects of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 2010;28:1574–1583.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Shimizu M, Hoshide S, et al. A bedtime dose of ARB was better than a morning dose in improving baroreflex sensitivity and urinary albumin excretion – the J-TOP study. Clin Exp Hypertens. 2012;34:488–492.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Nakamura T, Matsubara H. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 2010;32:416–422.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, et al. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 2008;21:948–954.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, et al. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension. 2008;51:69–76.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Gabbai FB, Borrelli S, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007;50:908–917.
   PubMed Web of Science ®Google Scholar
• Rahman M, Greene T, Phillips RA, et al. A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension. 2013;61:82–88.
   PubMed Web of Science ®Google Scholar
• Okeahialam B, Ohihoin E, Ajuluchukwu J. Chronotherapy in Nigerian hypertensives. Ther Adv Cardiovasc Dis. 2011;5:113–118.
   PubMedGoogle Scholar
• Wang C, Zhang J, Liu X, et al. Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens (Greenwich). 2013;15:48–54.
   PubMedGoogle Scholar
• Hermida RC, Calvo C, Ayala DE, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–1922.
   PubMed Web of Science ®Google Scholar
• Kasiakogias A, Tsioufis C, Thomopoulos C, et al. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens. 2015;33:393–400.
   PubMed Web of Science ®Google Scholar
• Zappe DH, Crikelair N, Kandra A, et al. Time of administration important? Morning versus evening dosing of valsartan. J Hypertens. 2015;33:385–392.
   PubMed Web of Science ®Google Scholar
• Yang K, Wang Y, Ding Y, et al. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats. Chronobiol Int. 2019;36:1058–1071.
   PubMed Web of Science ®Google Scholar
• Poulter NR, Savoloulos C, Anjum A, et al. Randomized crossover trial of the impact of morning or evening dosing of antihypertensive agents on 24-hour ambulatory blood pressure – the HARMONY trial. Hypertension. 2018;72:870–873.
   PubMed Web of Science ®Google Scholar
• Laffin LJ, Bakris GL. Has the sun set on nighttime dosing in uncomplicated hypertension? Hypertension. 2018;72:836–838.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757–764.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998;16:1823–1829.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145–153.
   PubMed Web of Science ®Google Scholar
• Svensson P, de Faire U, Sleight P, et al. Comparative effects of ramipril on ambulatory and office blood pressures. A HOPE substudy. Hypertension. 2001;38:e28–e32.
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003;289:2073–2082.
   PubMed Web of Science ®Google Scholar
• White WB, Black HR, Weber MA, et al. Comparison of effects of controlled-onset extended-release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 1998;81:424–431.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fapohunda J, Kostis JB. Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 2014;16:561–568.
   PubMed Web of Science ®Google Scholar
• Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
   PubMed Web of Science ®Google Scholar
• Sobiczewski W, Wirthwein M, Gruchala M, et al. Mortality in hypertensive patients with coronary heart disease depends on chronopharmacotherapy and dipping status. Pharmacol Rep. 2014;66:448–452.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2019 Oct 22. DOI:10.1093/eurheartj/ehy754.
   Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 2013;30:315–327.
   PubMed Web of Science ®Google Scholar
• Carter BL, Chrischilles EA, Rosenthal G, et al. Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial. J Clin Hypertens (Greenwich). 2014;16:115–121.
   PubMed Web of Science ®Google Scholar
• Rorie DA, Rogers A, Mackenzie IS, et al. Methods of a large prospective, randomized, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study. BMJ Open. 2016;6:e010313.
   PubMed Web of Science ®Google Scholar
• Kim SYH, Miller FG. Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime docing of blood pressure drugs. Clin Trials. 2015;12:557–563.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Diagnosis and management of hypertension: around-the-clock ambulatory blood pressure monitoring is substantially more effective and less costly than daytime office blood pressure measurements. Chronobiol Int. 2019;36:1515–1527.
   PubMed Web of Science ®Google Scholar
• Kanabrocki EL, George M, Hermida RC, et al. Day-night variations in blood levels of nitric oxide, T-TFPI and E-selectin. Clin Appl Thrombosis/Hemostasis. 2001;7:339–345.
   PubMed Web of Science ®Google Scholar
• Sole MJ, Martino TA. Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hyperthrophy and failure. J Appl Physiol. 2009;107:1318–1327.
   PubMed Web of Science ®Google Scholar
• Martino TA, Tata N, Simpson JA, et al. The primary benefits of angiotensin-converting anzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hyperthrophy. J Am Coll Cardiol. 2011;57:2020–2028.
   PubMed Web of Science ®Google Scholar
• Rana S, Prabhu SD, Young ME. Chronobiological influence over cardiovascular function. The Good, the Bad, and Ugly. Circ Res. 2020;126:258–279.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34:1270–1276.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 2011;22:2313–2321.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, et al. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol Int. 2013;30:340–352.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Diabetologia. 2016;59:255–265.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. Risk of incident chronic kidney disease is better reduced by bedtime tham upon awakening ingestion of hypertension medications. Hypertens Res. 2018;41:342–353.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes – 2012. Diabetes Care. 2012;35(Suppl 1):S11–S63.
   PubMed Web of Science ®Google Scholar
• Rydén L, Grant PJ, Anker SD, et al. The Task Force of diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiolofy (ESC) and European Association for the Study of Diabetes (EASD). ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013;34:3035–3087.
   PubMed Web of Science ®Google Scholar